Literature DB >> 20043882

The death effector domain-containing DEDD forms a complex with Akt and Hsp90, and supports their stability.

Nobuya Kurabe1, Mayumi Mori, Jun Kurokawa, Kaori Taniguchi, Hisatoshi Aoyama, Kazuhiro Atsuda, Akemi Nishijima, Nariaki Odawara, Saori Harada, Katsuhiko Nakashima, Satoko Arai, Toru Miyazaki.   

Abstract

Insulin secretion and glucose transport are the major mechanisms to balance glucose homeostasis. Recently, we found that the death effector domain-containing DEDD inhibits cyclin-dependent kinase-1 (Cdk1) function, thereby preventing Cdk1-dependent inhibitory phosphorylation of S6 kinase-1 (S6K1), downstream of phosphatidylinositol 3-kinase (PI3K), which overall results in maintenance of S6K1 activity. Here we newly show that DEDD forms a complex with Akt and heat-shock protein 90 (Hsp90), and supports the stability of both proteins. Hence, in DEDD(-/-) mice, Akt protein levels are diminished in skeletal muscles and adipose tissues, which interferes with the translocation of glucose-transporter 4 (GLUT4) upon insulin stimulation, leading to inefficient incorporation of glucose in these organs. Interestingly, as for the activation of S6K1, suppression of Cdk1 is involved in the stabilization of Akt protein by DEDD, since diminishment of Cdk1 in DEDD(-/-) cells via siRNA expression or treatment with a Cdk1-inhibitor, increases both Akt and Hsp90 protein levels. Such multifaceted involvement of DEDD in glucose homeostasis by supporting both insulin secretion (via maintenance of S6K1 activity) and glucose uptake (via stabilizing Akt protein), may suggest an association of DEDD-deficiency with the pathogenesis of type 2 diabetes mellitus. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20043882      PMCID: PMC2833336          DOI: 10.1016/j.bbrc.2009.12.137

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  39 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

2.  Mitotic regulation of ribosomal S6 kinase 1 involves Ser/Thr, Pro phosphorylation of consensus and non-consensus sites by Cdc2.

Authors:  O Jameel Shah; Sourav Ghosh; Tony Hunter
Journal:  J Biol Chem       Date:  2003-02-13       Impact factor: 5.157

3.  Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function.

Authors:  Andrea D Basso; David B Solit; Gabriela Chiosis; Banabihari Giri; Philip Tsichlis; Neal Rosen
Journal:  J Biol Chem       Date:  2002-08-09       Impact factor: 5.157

4.  Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta.

Authors:  Robert S Garofalo; Stephen J Orena; Kristina Rafidi; Anthony J Torchia; Jeffrey L Stock; Audrey L Hildebrandt; Timothy Coskran; Shawn C Black; Dominique J Brees; Joan R Wicks; John D McNeish; Kevin G Coleman
Journal:  J Clin Invest       Date:  2003-07-03       Impact factor: 14.808

5.  Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol.

Authors:  David B Solit; Andrea D Basso; Adam B Olshen; Howard I Scher; Neal Rosen
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

Review 6.  Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control.

Authors:  Sean Oldham; Ernst Hafen
Journal:  Trends Cell Biol       Date:  2003-02       Impact factor: 20.808

Review 7.  Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.

Authors:  Diane C Fingar; John Blenis
Journal:  Oncogene       Date:  2004-04-19       Impact factor: 9.867

Review 8.  Tor signalling in bugs, brain and brawn.

Authors:  Estela Jacinto; Michael N Hall
Journal:  Nat Rev Mol Cell Biol       Date:  2003-02       Impact factor: 94.444

Review 9.  Integration of growth factor and nutrient signaling: implications for cancer biology.

Authors:  Alykhan F Shamji; Paul Nghiem; Stuart L Schreiber
Journal:  Mol Cell       Date:  2003-08       Impact factor: 17.970

Review 10.  Targeting mTOR signaling for cancer therapy.

Authors:  Shile Huang; Peter J Houghton
Journal:  Curr Opin Pharmacol       Date:  2003-08       Impact factor: 5.547

View more
  5 in total

1.  MCL1 and DEDD Promote Urothelial Carcinoma Progression.

Authors:  Jonathan E Rosenberg; William C Hahn; Andrew L Hong; Jennifer L Guerriero; Mihir B Doshi; Bryan D Kynnap; Won Jun Kim; Anna C Schinzel; Rebecca Modiste; Amy J Schlauch; Rosalyn M Adam; David J Kwiatkowski; Rameen Beroukhim; Anthony Letai
Journal:  Mol Cancer Res       Date:  2019-02-18       Impact factor: 5.852

2.  Death effector domain-containing protein (DEDD) is required for uterine decidualization during early pregnancy in mice.

Authors:  Mayumi Mori; Miwako Kitazume; Rui Ose; Jun Kurokawa; Kaori Koga; Yutaka Osuga; Satoko Arai; Toru Miyazaki
Journal:  J Clin Invest       Date:  2010-12-06       Impact factor: 14.808

3.  Oral supplementations with L-glutamine or L-alanyl-L-glutamine do not change metabolic alterations induced by long-term high-fat diet in the B6.129F2/J mouse model of insulin resistance.

Authors:  Patricia Martins Bock; Mauricio Krause; Helena Trevisan Schroeder; Gabriela Fernandes Hahn; Hilton Kenji Takahashi; Cinthia Maria Schöler; Graziella Nicoletti; Luiz Domingos Zavarize Neto; Maria Inês Lavina Rodrigues; Maciel Alencar Bruxel; Paulo Ivo Homem de Bittencourt
Journal:  Mol Cell Biochem       Date:  2015-11-03       Impact factor: 3.396

Review 4.  Developmental regulation of decidual cell polyploidy at the site of implantation.

Authors:  Julie M Sroga; Xinghong Ma; Sanjoy K Das
Journal:  Front Biosci (Schol Ed)       Date:  2012-06-01

Review 5.  The decidua-the maternal bed embracing the embryo-maintains the pregnancy.

Authors:  Mayumi Mori; Agnes Bogdan; Timea Balassa; Timea Csabai; Júlia Szekeres-Bartho
Journal:  Semin Immunopathol       Date:  2016-06-10       Impact factor: 9.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.